Log in
Enquire now
‌

O2M Technologies, LLC SBIR Phase I Award, March 2018

A SBIR Phase I contract was awarded to O2M Technologies, LLC in March, 2018 for $358,445.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

OverviewStructured DataIssuesContributors

Contents

sbir.gov/node/1572831
Is a
SBIR/STTR Awards
SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient
‌
O2M Technologies, LLC
0
Government Agency
0
Government Branch
National Institutes of Health
National Institutes of Health
0
Award Type
SBIR0
Contract Number (US Government)
1R43CA224840-010
Award Phase
Phase I0
Award Amount (USD)
358,4450
Date Awarded
March 1, 2018
0
End Date
February 28, 2019
0
Abstract

Abstract Approximately two third of cancer patients are treated with radiationeither alone or in combination with chemotherapy or surgeryRadiation can damage normal cells and this damage can lead to long term side effectsThereforereduction in overall delivered radiation is beneficial to patientsquality of life and can potentially save healthcare costOxygen guided radiation therapyOGRTis expected to reduce the high radiation dose volume by reducing the dose to well oxygenated tumor tissuethus preserving the structure and integrity of irradiated tissues and reducing side effectsCurrentlythere is no widely available noninvasive clinical or preclinical method to map oxygen partial pressurepOwith high accuracyAvailable methods either do not provide absolute oxygen measurement deep inside the bodyor are not suitable for three dimensional oxygen map acquisitionAbsence of preclinicalanimaloxygen imaging data is the major impediment in development of evidence base for advancing oxygen based treatments into clinicsThereforeproviding research community with oxygen imaging instruments and services is the first step in achieving these goalsThis Phase I SBIR grant will transition the research lab based low frequencymTMHzelectron paramagnetic resonance oxygen imagingEPROIequipment to a commercial benchtop unitJIVAEPROI is a non invasive oxygen imaging technique with pOresolution oftorr and spatial resolution ofmmIt has been widely applied to map hypoxia in animal solid tumors to evaluate the efficiency of anti tumor drugs and recentlyto guide tumor radiation therapyIn aimwe will develop acquisition and image processing software and other accessories that will make JIVAa turnkey instrumentthat can be operated by a technician with no prior experience in EPROIIn aimwe will construct an oxygen imager prototypeJIVAand develop standard operating procedure and manualThe success of this proposal will result in a commercial oxygen imager for cancer research in cancer centersuniversities and pharmaceutical industryOur long term goal is to combine this technology with clinical image guided radiation therapyIMRTequipment for enhanced and targeted radiation therapy Narrative Oxygen is the single most important molecule for aerobic life formsNo reliable preclinical noninvasive method for three dimensional molecular oxygen mapping is currently available to scientists for expanding radiation treatment and cancer biology researchThis proposal is designed to bridge this gapWe will develop a prototype of oxygen imager based on low frequency electron paramagnetic resonance oxygen imagingEPROItechnique for preclinical applications

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like O2M Technologies, LLC SBIR Phase I Award, March 2018

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.